Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9528994
Target of the phosphoinositide 3-kinase pathway
granted -
US 9527917
Nucleic acid encoding anti-OX40 antibodies
granted -
US 9527887
Treatments for gastrointestinal disorders
granted -
US 9527889
RFamide-related peptides and methods thereof
granted -
US 9527878
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
granted -
US 9527868
ETP derivatives
granted -
US 9527841
Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors
granted -
US 9527807
Sulfonamide derivative and use thereof
granted -
US 9527819
Pyridazine compounds, compositions and methods
granted -
US 9526824
Nanochanneled device and related methods
granted -
US 9526803
Diagnostic chewing gum for pathogens
granted -
US 9526777
Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein
granted -
US 9526796
Peptide-based in vivo siRNA delivery system
granted -
US 9526765
Delivery of therapeutic agents by a collagen binding protein
granted -
US 9526786
Thermostabilization of proteins
granted -
US 9526747
Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
granted -
US 9522910
Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
granted -
US 9523691
Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diagnosis
granted -
US 9523675
Insect repellent and attractants
granted -
US 9522963
Dissolution of oxidized cellulose
granted -
US 9523094
Methods of treating kennedy's disease
granted -
US 9523079
Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
granted -
US 9522948
GP100-specific T cell receptors and related materials and methods of use
granted -
US 9522180
Peptide conjugated particles
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.